GARBOWSKI v. TOKAI PHARMACEUTICALS, INC.

C.A. No. 16-CV-11963-MLW, C.A. No. 16-CV-11992-MLW.

302 F.Supp.3d 441 (2018)

Michael GARBOWSKI, et al., Plaintiffs, v. TOKAI PHARMACEUTICALS, INC., et al., Defendants. Vaibhav Doshi, et al., Plaintiffs, v. Tokai Pharmaceuticals, Inc., et al., Defendants.

United States District Court, D. Massachusetts.

Filed March 16, 2018.

Editors Note
Applicable Law: 12 U.S.C. § 22
Cause: 12 U.S.C. § 22 Securities Fraud
Nature of Suit: 850 Securities / Commodities
Source: PACER


Attorney(s) appearing for the Case

Joseph H. Weiss , Weisslaw LLP, New York, NY, Thomas G. Shapiro , Adam M. Stewart , Shapiro Haber & Urmy LLP, David Pastor , Pastor Law Office, LLP, Boston, MA, for Plaintiffs.

Boris Feldman , Wilson Sonsini Goodrich & Rosati, Palo Alto, CA, Gideon A. Schor , Wilson Sonsini Goodrich & Rosati, New York, NY, Michael J. Pineault , Clements & Pineault, LLP, S. Elaine McChesney , Morgan, Lewis & Bockius LLP, Boston, MA, Charlene Sachi Shimada , Lucy Wang , Morgan Lewis & Bockius LLP, San Francisco, CA, for Defendants.


MEMORANDUM AND ORDER

In these consolidated class actions, it is alleged that Tokai Pharmaceuticals, Inc. and several of its officers, directors, and underwriters committed securities fraud in connection with the development of galeterone, an experimental drug. On September 30, 2016, Steven Maxon...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases